Tulane University Urology

Topics

• Kidney Stones and Urolithiasis Treatments 481
• Sexual function and dysfunction studies 461
• Prostate Cancer Treatment and Research 315
• Prostate Cancer Diagnosis and Treatment 162
• Renal cell carcinoma treatment 134
• Bladder and Urothelial Cancer Treatments 125
• Pediatric Urology and Nephrology Studies 73
• Urological Disorders and Treatments 72
• Urinary Bladder and Prostate Research 69
• Sperm and Testicular Function 65
• Hormonal and reproductive studies 57
• Pelvic floor disorders treatments 54

Most cited

1. Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

   The New England journal of medicine · 2021 · 2,264 citations · Oliver Sartor

2. 177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial.

   Lancet (London, England) · 2024 · 270 citations · Oliver Sartor

3. Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.

   The New England journal of medicine · 2025 · 134 citations · Michael Woods

4. Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial.

   The Lancet. Oncology · 2023 · 275 citations · Oliver Sartor

5. Thulium Fiber Laser Versus Holmium:Yttrium Aluminum Garnet for Lithotripsy: A Systematic Review and Meta-analysis.

   European urology · 2024 · 56 citations · Manoj Monga

6. Incidence of Kidney Stones in the United States: The Continuous National Health and Nutrition Examination Survey.

   The Journal of urology · 2022 · 185 citations ·